• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

乙酰胆碱受体抗体、肌肉特异性酪氨酸激酶抗体和低密度脂蛋白受体相关蛋白 4 抗体共存:来自印度次大陆的一种罕见且独特的重症肌无力亚型。

Anti-AChR, MuSK, and LRP4 antibodies coexistence: A rare and distinct subtype of myasthenia gravis from Indian subcontinent.

机构信息

Department of Neuromicrobiology, National Institute of Mental Health and Neurosciences, Hosur Road, Bangalore, 560029, India.

Department of Neurology and Clinical Neurosciences, National Institute of Mental Health and Neurosciences, Hosur Road, Bangalore, 560029, India.

出版信息

Clin Chim Acta. 2018 Nov;486:34-35. doi: 10.1016/j.cca.2018.07.011. Epub 2018 Jul 10.

DOI:10.1016/j.cca.2018.07.011
PMID:30006288
Abstract

BACKGROUND

Myasthenia gravis is B-cell mediated autoimmune disease and is associated with antibodies against the acetylcholine receptor (AChR), muscle-specific kinase (MuSK) and lipoprotein-related protein 4 (LRP4) in the postsynaptic membrane at the neuromuscular junction. There are few studies on the concurrent presence of two positive antibodies in the sera of patients with myasthenia gravis.

CASE DESCRIPTION

A 32-year male admitted to the hospital with progressive neuromuscular weakness. He was diagnosed with Myasthenia gravis disorder mimicking Amyotrophic Lateral Sclerosis. We herein report a rare co-existence of three antibodies (anti-AChR, MuSK, and LRP4 antibodies) in the patient's serum.

CONCLUSION

We present a detailed clinical and laboratory analysis of the patient. This case report will emphasize the importance of evaluating anti-MuSK and anti-LRP4 antibodies even in patients with anti-AChR antibodies.

摘要

背景

重症肌无力是 B 细胞介导的自身免疫性疾病,与神经肌肉接头突触后膜上的乙酰胆碱受体 (AChR)、肌肉特异性激酶 (MuSK) 和脂蛋白相关蛋白 4 (LRP4) 抗体有关。重症肌无力患者血清中同时存在两种阳性抗体的研究较少。

病例描述

一名 32 岁男性因进行性神经肌肉无力入院。他被诊断为肌萎缩侧索硬化症样重症肌无力障碍。我们在此报告了一种罕见的患者血清中同时存在三种抗体(抗 AChR、MuSK 和 LRP4 抗体)的情况。

结论

我们对患者进行了详细的临床和实验室分析。本病例报告将强调即使在抗 AChR 抗体阳性的患者中,评估抗 MuSK 和抗 LRP4 抗体的重要性。

相似文献

1
Anti-AChR, MuSK, and LRP4 antibodies coexistence: A rare and distinct subtype of myasthenia gravis from Indian subcontinent.乙酰胆碱受体抗体、肌肉特异性酪氨酸激酶抗体和低密度脂蛋白受体相关蛋白 4 抗体共存:来自印度次大陆的一种罕见且独特的重症肌无力亚型。
Clin Chim Acta. 2018 Nov;486:34-35. doi: 10.1016/j.cca.2018.07.011. Epub 2018 Jul 10.
2
MuSK myasthenia gravis IgG4 disrupts the interaction of LRP4 with MuSK but both IgG4 and IgG1-3 can disperse preformed agrin-independent AChR clusters.肌肉特异性激酶(MuSK)型重症肌无力免疫球蛋白G4(IgG4)会破坏低密度脂蛋白受体相关蛋白4(LRP4)与MuSK之间的相互作用,但IgG4和IgG1 - 3均可使预先形成的不依赖聚集蛋白的乙酰胆碱受体(AChR)簇分散。
PLoS One. 2013 Nov 7;8(11):e80695. doi: 10.1371/journal.pone.0080695. eCollection 2013.
3
Flow Cytofluorimetric Analysis of Anti-LRP4 (LDL Receptor-Related Protein 4) Autoantibodies in Italian Patients with Myasthenia Gravis.意大利重症肌无力患者中抗LRP4(低密度脂蛋白受体相关蛋白4)自身抗体的流式细胞荧光分析
PLoS One. 2015 Aug 18;10(8):e0135378. doi: 10.1371/journal.pone.0135378. eCollection 2015.
4
Anti-LRP4 autoantibodies in AChR- and MuSK-antibody-negative myasthenia gravis.抗 LRP4 自身抗体在乙酰胆碱受体抗体和肌肉特异性激酶抗体阴性的重症肌无力中的作用。
J Neurol. 2012 Mar;259(3):427-35. doi: 10.1007/s00415-011-6194-7. Epub 2011 Aug 5.
5
An update on laboratory diagnosis in myasthenia gravis.重症肌无力的实验室诊断进展。
Clin Chim Acta. 2015 Sep 20;449:43-8. doi: 10.1016/j.cca.2015.07.030. Epub 2015 Aug 1.
6
[Autoantibodies detected in acetylcholine receptor antibody-negative myasthenia gravis].[在乙酰胆碱受体抗体阴性重症肌无力中检测到的自身抗体]
Rinsho Byori. 2014 Mar;62(3):255-60.
7
Autoantibodies to lipoprotein-related protein 4 in patients with double-seronegative myasthenia gravis.双血清阴性重症肌无力患者中脂蛋白相关蛋白4自身抗体
Arch Neurol. 2012 Apr;69(4):445-51. doi: 10.1001/archneurol.2011.2393. Epub 2011 Dec 12.
8
Electrophysiological findings in patients with low density lipoprotein receptor related protein 4 positive myasthenia gravis.载脂蛋白脂蛋白受体 4 阳性重症肌无力患者的电生理发现。
Eur J Neurol. 2016 Nov;23(11):1635-1641. doi: 10.1111/ene.13081. Epub 2016 Jul 14.
9
A comprehensive analysis of the epidemiology and clinical characteristics of anti-LRP4 in myasthenia gravis.抗 LRP4 抗体在重症肌无力中的流行病学和临床特征的综合分析。
J Autoimmun. 2014 Aug;52:139-45. doi: 10.1016/j.jaut.2013.12.004. Epub 2013 Dec 24.
10
Myasthenia gravis with muscle-specific tyrosine kinase antibodies: A narrative review.重症肌无力伴肌肉特异性酪氨酸激酶抗体:叙述性综述。
Muscle Nerve. 2018 Sep;58(3):344-358. doi: 10.1002/mus.26107. Epub 2018 Mar 25.

引用本文的文献

1
Myasthenia gravis with double-seropositive acetylcholine receptor and low-density lipoprotein receptor-related protein 4 antibodies combined with muscle atrophy: a case report and literature review.重症肌无力合并乙酰胆碱受体和低密度脂蛋白受体相关蛋白4抗体双阳性并伴有肌肉萎缩:一例报告及文献复习
Front Immunol. 2025 Apr 28;16:1545579. doi: 10.3389/fimmu.2025.1545579. eCollection 2025.
2
Telitacicept in combination with B-cell depletion therapy in MuSK antibody-positive myasthenia gravis: a case report and literature review.泰利妥昔单抗联合B细胞清除疗法治疗MuSK抗体阳性重症肌无力:一例病例报告及文献综述
Front Immunol. 2024 Nov 18;15:1456822. doi: 10.3389/fimmu.2024.1456822. eCollection 2024.
3
Characterization of LRP4/Agrin Antibodies From a Patient With Myasthenia Gravis.
LRP4/Agrin 抗体在重症肌无力患者中的特征。
Neurology. 2021 Sep 7;97(10):e975-e987. doi: 10.1212/WNL.0000000000012463. Epub 2021 Jul 7.
4
Diagnosis of Myasthenia Gravis.重症肌无力的诊断
J Clin Med. 2021 Apr 16;10(8):1736. doi: 10.3390/jcm10081736.
5
A Patient with Fulminant Myasthenia Gravis Is Seropositive for Both AChR and LRP4 Antibodies, Complicated by Autoimmune Polyglandular Syndrome Type 3.一位暴发性重症肌无力患者的乙酰胆碱受体和 LRP4 抗体均呈阳性,合并 3 型自身免疫性多腺体综合征。
Intern Med. 2020 Sep 1;59(17):2177-2181. doi: 10.2169/internalmedicine.4708-20. Epub 2020 May 26.
6
Seronegative Myasthenia Gravis in Association with Human T-Lymphotropic Virus Type 1 and Hepatitis C.1型人类嗜T淋巴细胞病毒和丙型肝炎相关的血清阴性重症肌无力
Saudi J Med Med Sci. 2019 Jan-Apr;7(1):53-54. doi: 10.4103/sjmms.sjmms_118_18. Epub 2018 Dec 14.